If you are considering pregnancy or become pregnant while taking a GLP-1 medication, contact your provider promptly, as these agents are generally discontinued before conception due to limited safety data in pregnancy
The three most recent Phase 3 readouts are: TRIUMPH-4 (December 2025) showing 28.7% weight reduction at 68 weeks in obesity with knee osteoarthritis, TRANSCEND-T2D-1 (March 2026) showing A1C reductions up to 2.0% and 16.8% weight loss at 40 weeks in type 2 diabetes, and TRIUMPH-1 (May 2026) showing up to 25.0% weight reduction at 80 weeks in the pivotal obesity trial
glucagon-like peptide-1 receptor agonists increased by 600% among adolescents and young adults from 2020 to 2023, with a particularly significant rise in young women and girls
L-Carnitine Injection L-carnitine is an amino acid derivative that plays a crucial role in the bodys energy production processes
A division of laborpharmacology for initiation, nutrition and microbial-context modulation for preservationoffers a pragmatic and biologically defensible model for sustainable obesity care
Medical Disclaimer This website is for educational and informational purposes only